These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6398675)

  • 41. [The resistance of P. falciparum malaria to amino-4 quinoleines].
    Charmot G
    Lyon Med; 1971; 225():Suppl:143-4. PubMed ID: 4935511
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chloroquine-resistant Plasmodium falciparum malaria from Tanzania sensitivity tested in vivo].
    Olsen VV; Fogh S
    Ugeskr Laeger; 1981 Apr; 143(16):1021-2. PubMed ID: 7015650
    [No Abstract]   [Full Text] [Related]  

  • 43. [Malaria prevention].
    Bygbjerg I; Fogh S; Olsen VV; Black F; Effersøe P; Jepsen S
    Ugeskr Laeger; 1983 Jan; 145(4):262-4. PubMed ID: 6342246
    [No Abstract]   [Full Text] [Related]  

  • 44. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
    Randrianarivelojosia M; Raharimalala LA; Randrianasolo L; Ratsimbasoa A; Rason MA; Ariey F; Jambou R
    Ann Trop Med Parasitol; 2001 Apr; 95(3):237-43. PubMed ID: 11339883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
    Rason MA; Andrianantenaina HB; Ariey F; Raveloson A; Domarle O; Randrianarivelojosia M
    Am J Trop Med Hyg; 2007 Jun; 76(6):1079-83. PubMed ID: 17556614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline.
    Sparatore A; Basilico N; Casagrande M; Parapini S; Taramelli D; Brun R; Wittlin S; Sparatore F
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3737-40. PubMed ID: 18538567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasmodium falciparum malaria resistant to 4-aminoquinolines, contracted in East Africa].
    Sansonetti P; Dupont B; Le Bras J; Charmot G; Lapresle C
    Presse Med; 1983 Sep; 12(32):1996-7. PubMed ID: 6225105
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea.
    Casey GJ; Ginny M; Uranoli M; Mueller I; Reeder JC; Genton B; Cowman AF
    Am J Trop Med Hyg; 2004 Mar; 70(3):251-5. PubMed ID: 15031512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of Plasmodium falciparum resistance to 4-Aminoquinolines (Chloroquine) in Sabah, Malaysia.
    Maqsudur Rahman KM
    J Trop Med Hyg; 1980 Dec; 83(6):259-64. PubMed ID: 7003166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
    Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
    Brueckner RP; Coster T; Wesche DL; Shmuklarsky M; Schuster BG
    Antimicrob Agents Chemother; 1998 May; 42(5):1293-4. PubMed ID: 9593172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
    Musonda CC; Little S; Yardley V; Chibale K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A new case of Plasmodium falciparum malaria resistance to chloroquine in Africa (Rwanda) (author's transl)].
    Mafart Y; Pieron R; Melchior JC
    Med Trop (Mars); 1981; 41(6):677-80. PubMed ID: 7040906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
    Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
    Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
    Solomon VR; Puri SK; Srivastava K; Katti SB
    Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Summary of recent abstracts. 3. Malaria.
    Field JW
    Trop Dis Bull; 1971 Apr; 68(4):393-411. PubMed ID: 4996942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.